# Coronary Sinus Reducer Objective Impact on Symptoms, MRI Ischaemia and Microvascular Resistance

> **NCT04892537** · NA · UNKNOWN · sponsor: **Imperial College London** · enrollment: 50 (estimated)

## Conditions studied

- Refractory Angina

## Interventions

- **DEVICE:** Coronary Sinus Reducer
- **PROCEDURE:** Placebo Procedure

## Key facts

- **NCT ID:** NCT04892537
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-05-21
- **Primary completion:** 2024-01
- **Final completion:** 2024-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-10-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04892537

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04892537, "Coronary Sinus Reducer Objective Impact on Symptoms, MRI Ischaemia and Microvascular Resistance". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04892537. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*